Friday 21st August 2009 |
Text too small? |
Fisher & Paykel Healthcare forecast earnings growth in 2010 of 25% as higher-than-expected sales make up for the impact of a stronger kiwi dollar on overseas sales.
Net profit will be $75 million to $80 million in the year ending March 31, chief executive Michael Daniell told shareholders at their annual meeting today. Trading so far in the first half has been better than was expected in May, when the company previously gave profit guidance.
“Demand has been strong, and we have seen accelerating growth, as a result of the introduction of new products, in the OSA product group,” Daniell said, referring to the company’s obstructive sleep apnea products.
F&P Healthcare shares rose 2.5% to $3.33 and have climbed 11% in the past month.
Businesswire.co.nz
No comments yet
NZ dollar rally may limit profit gains for Fisher and Paykel Healthcare, brokerage says
FISHER & PAYKEL HEALTHCARE ANNOUNCES NEW NASAL PILLOWS MASK AT INVESTOR DAY
Shares in Fisher and Paykel Healthcare third-best performer on NZX 50 after raising earnings forecast
Fisher and Paykel Healthcare raises 2014 earnings forecast on higher sales, margins
F and P Healthcare shares jump to highest in more than 2 years on profit outlook
F and P Healthcare beats 2013 guidance, forecasts boost in 2014 profit; shares gain to 2 1/2 year high
F and P Healthcare shares rise to two-year high as First NZ raises rating on better outlook
Fisher & Paykel Healthcare
F and P Healthcare lifts guidance as sales grow, margins widen; shares rally
F&P Healthcare 1H profit rises 18%, on record sales, wider margins